Company Growth (employees)
23andMe was founded in 2006 and is headquartered in Mountain View, US
Key People at 23andMe
Anne Wojcicki
CEO and Co-founder
Dean Schorno
CFO & Head of Operations
Angela Calman
Vice President of Communications
Emily Drabant Conley
Vice President of Business Development
Joyce Tung
Vice President of Research
Jonathan Ward
Vice President, International
Kathy Hibbs
Chief Legal and Regulatory Officer
Steve Lemon
VP, Product & Engineering
23andMe Office Locations
23andMe has an office in Mountain View
Mountain View, US (HQ)
899 W Evelyn Ave
23andMe Data and Metrics
Summary Metrics
Founding Date | 2006 |
Total Funding | $236.1 m |
Latest funding size | $1.7 m |
Time since last funding | 10 months |
Investors | Fidelity Management & Research, WuXi Healthcare Ventures, MPM Capital, National Institutes of Health, GV, Casdin Capital, New Enterprise Associates, Johnson & Johnson Development Corporation, Xfund |
23andMe's latest funding round in October 2016 was reported to be $1.7 m. In total, 23andMe has raised $236.1 m. 23andMe's latest valuation is reported to be $1.1 b.
23andMe Financial Metrics
USD
Market valuation | 1.1 b |
23andMe Median Salaries
Source: 13 public H-1B filings from 23andMe
Market Position of 23andMe
Traffic Overview of 23andMe
23andMe Online and Social Media Presence
23andMe News and Updates
April 10, 2017
The FDA’s 23andMe decision will also change the rules for all at-home medical genetic testing
Doctors are losing their role as the gatekeeper of our health information, for better or worse. Last week, the US Food and Drug Administration made…
April 08, 2017
How 23andMe Won Back the Right to Foretell Your Diseases
Using science and lots of focus groups, the company convinced the FDA that people can understand genetic testing results. The post How 23andMe Won Back the Right to Foretell Your Diseases appeared first on WIRED.
April 07, 2017
Patient groups have a message for anyone thinking of taking 23andMe's new test
23andMe can once again tell you whether you have an increased risk of developing certain diseases.
By the end of the month, 23andMe users will start to see some results among their other health and ancestry reports, including the results that tell you if you have an increas…
April 06, 2017
You can finally get an FDA-approved genetic test for diseases from 23andMe
23andMe is already telling curious customers everywhere they're descended from, but the genetics service has finally received permission to provide a little more information based on DNA samples.
23andMe now has approval from the Food and Drug Administration to tell its users if they're at a hi…
April 06, 2017
23andMe is finally allowed to tell you if you have the genes for Parkinson’s
The Food and Drug Administration finally gave 23andMe a long sought-after green light today to sell to consumers genetic tests and their accompanying health risk reports for up to 10 diseases, including late-onset Alzheimer’s and Parkinson’s. Read More
April 06, 2017
23andMe just got the OK to tell you if you have an increased risk of Alzheimer's, Parkinson's and other diseases
23andMe can once again tell you if you have an increased risk of developing certain diseases.
In November 2013, the FDA barred 23andMe from sending any of that data related to health to customers because of concerns that the company was misrepresenting genetic tests as medi…